Covaxin Efficacy Yet to be Reviewed by Govt, Bharat Biotech to Submit Data in 2-3 Days: Report

Bharat Biotech, which developed the drug that has shown an efficacy of 81% in the initial phase 3 trial analysis, would submit the clinical trial data to the government in the coming days for review, said a senior official at CDSCO, which is under the Drugs Controller General of India (DCGA).

Latest News of India, Sports, Tech, Technology 2021 from Top India News- News18.com for more info CLICK HERE